K
Kopal
About Kopal
Data last updated:
Kopal is a Director at Wirksam Pharma Private Limited (since 2025). The company operates in Trading. Wirksam Pharma Private Limited reported revenue of ₹3.91 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Wirksam Pharma Private Limited U24232RJ2015PTC048194 | Director | 26 Feb 2025 | 2015 | ₹3.91 Cr (FY 2024) | Active |
Board colleagues of Kopal
| Name | DIN | Company | Designation |
|---|---|---|---|
| Deepak Mittal | 08049462 | Wirksam Pharma Private Limited | Director |
| Priyanka Rawat | 07260206 | Wirksam Pharma Private Limited | Director |
| Sangita | 07275982 | Wirksam Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Kopal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kopal
Kopal currently holds 1 directorship: Wirksam Pharma Private Limited (Director, since 26 Feb 2025, revenue ₹3.91 Cr (FY 2024)).
Kopal was first appointed on 26 Feb 2025 as Director at Wirksam Pharma Private Limited.
The current boards of Kopal's companies include Deepak Mittal (Wirksam Pharma Private Limited), Priyanka Rawat (Wirksam Pharma Private Limited), Sangita (Wirksam Pharma Private Limited).